Charles River Laboratories (CRL) to address the topic of non-human primate supply

November 30, 2022 10:04 AM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
(Updated - November 30, 2022 10:36 AM EST)

Charles River Laboratories (NYSE: CRL) disclosed:

Charles River Laboratories International, Inc. (“Charles River”, the “Company”, or the “Registrant”) is virtually presenting at the Evercore ISI 5th Annual HealthCONx Conference, on Wednesday, November 30, 2022, at approximately 9:40 a.m. ET.

During this presentation, management of the Registrant intends to address the topic of non-human primate (NHP) supply following the November 16, 2022 announcement by the U.S. Department of Justice through the U.S. Attorney’s Office for the Southern District of Florida that a Cambodian NHP supplier and two Cambodian officials had been criminally charged in connection with illegally importing NHPs into the United States (the “DOJ proceedings”). In particular, in recognition of the numerous investment analyst and media reports related to NHP pricing, the NHP supply chain, and the DOJ proceedings, the Company made statements to the following effect:

  • a.Charles River was not named or referenced in the DOJ proceedings, and the Company does not have any direct supply contracts with the indicted Cambodian supplier.
  • b.Charles River has global supply sources, including other sources in Cambodia, which is the primary country of origin of NHP imports to the United States and to Charles River. However, in light of the indictment, and subsequent statements made by the Cambodia government, Charles River is operating under the expectation that for some time period supply of Cambodia-sourced NHPs will be difficult to obtain in the United States; and
  • c.The Company is diligently working to mitigate any Cambodia NHP supply impact with ongoing efforts to procure NHPs under different supply arrangements and from other global sources

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Hot Corp. News, Litigation, Trader Talk, Trading Halts